Schroder UK Alpha Income C IncomeRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -7.8 | 14.7 | 1.5 | 5.8 | 11.2 | |
+/-Cat | 4.8 | -3.1 | 4.9 | -0.9 | -0.1 | |
+/-B’mrk | - | - | - | -1.8 | -0.3 | |
Category: UK Equity Income | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 20/09/2024 | GBP 1.69 | |
Day Change | -1.00% | |
Morningstar Category™ | UK Equity Income | |
IA (formerly IMA) Sector | UK Equity Income | |
ISIN | GB00B073HX38 | |
Fund Size (Mil) 20/09/2024 | GBP 63.59 | |
Share Class Size (Mil) 20/09/2024 | GBP 0.23 | |
Max Initial Charge | - | |
Ongoing Charge 06/02/2024 | 0.75% |
Investment Objective: Schroder UK Alpha Income C Income |
The Fund aims to provide income and capital growth in excess of the FTSE All Share (Gross Total Return) index (after fees have been deducted) over a three to five year period by investing in equity and equity related securities of UK companies. The Fund is actively managed and invests at least 80% of its assets in equity and equity related securities of UK companies. These are companies that are incorporated, headquartered or have their principal business activities in the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Sue Noffke 01/03/2020 | ||
Matthew Bennison 01/03/2020 | ||
Inception Date 06/05/2005 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Schroder UK Alpha Income C Income | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.29 |
Shell PLC | Energy | 6.64 |
GSK PLC | Healthcare | 4.93 |
HSBC Holdings PLC | Financial Services | 4.61 |
Unilever PLC | Consumer Defensive | 3.78 |
Increase Decrease New since last portfolio | ||
Schroder UK Alpha Income C Income |